Skip to main content

Advertisement

SpringerLink
Log in

New Developments in Behavioral Treatments for Substance Use Disorders

  • Substance Use and Related Disorders (JR McKay, Section Editor)
  • Published:
Current Psychiatry Reports Aims and scope Submit manuscript

Abstract

After decades of defining which behavioral treatments are effective for treating addictions, the focus has shifted to exploring how these treatments work, how best to disseminate and implement them in the community, and what underlying factors can be manipulated in order to increase the rates of treatment success. These pursuits have led to advances in our understanding of the mechanisms of treatment effects, the incorporation of technology into the delivery of current treatments and development of novel applications to support relapse prevention, as well as the inclusion of neurocognitive approaches to target the automatic and higher-order processes underlying addictive behaviors. Although such advances have the promise of leading to better treatments for more individuals, there is still much work required for these promises to be realized. The following review will highlight some of these recent developments and provide a glimpse into the future of behavioral treatments.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Bates ME, Bowden SC, Barry D. Neurocognitive impairment associated with alcohol use disorders: implications for treatment. Exp Clin Psychopharmacol. 2002;10:193–212.

    PubMed  CAS  Google Scholar 

  2. Jovanovski D, Erb S, Zakzanis KK. Neurocognitive deficits in cocaine users: a quantitative review of the evidence. J Clin Exp Neuropsychol. 2005;27:189–204.

    PubMed  Google Scholar 

  3. Bates ME, Buckman JF, Nguyen TT. A role for cognitive rehabilitation in increasing the effectiveness of treatment for alcohol use disorders. Neuropsychol Rev. 2013;23:27–47. Thorough review of the evidence regarding neurocognitive effects of alcohol, and current approaches that incorporate cognitive rehabilitation.

    PubMed  Google Scholar 

  4. Dutra L, Stathopoulou G, Basden SL, et al. A meta-analytic review of psychosocial interventions for substance use disorders. Am J Psychiatry. 2008;165:179–87.

    PubMed  Google Scholar 

  5. Lussier JP, Heil SH, Mongeon JA, et al. A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Addiction. 2006;101:192–203.

    PubMed  Google Scholar 

  6. Hagedorn HJ, Noorbaloochi S, Simon AB, et al. Rewarding early abstinence in veterans health administration addiction clinics. J Subst Abuse Treat. 2013;45:109–17.

    PubMed  Google Scholar 

  7. Petry NM, Carroll KM. Contingency management is efficacious in opioid-dependent outpatients not maintained on agonist pharmacotherapy. Psychol Addict Behav. 2013 Mar 25 [Epub ahead of print].

  8. Reback CJ, Peck JA, Dierst-Davies R, et al. Contingency management among homeless, out-of-treatment men who have sex with men. J Subst Abuse Treat. 2010;39:255–63.

    PubMed  Google Scholar 

  9. Petry NM, Alessi SM, Rash CJ. A randomized study of contingency management in cocaine-dependent patients with severe and persistent mental health disorders. Drug Alcohol Depend. 2013;130:234–7.

    PubMed  Google Scholar 

  10. McDonell MG, Srebnik D, Angelo F, et al. Randomized controlled trial of contingency management for stimulant use in community mental health patients with serious mental illness. Am J Psychiatry. 2013;170:94–101.

    PubMed  Google Scholar 

  11. Petry NM, Alessi SM, Rash CJ. Contingency management treatments decrease psychiatric symptoms. J Consult Clin Psychol. 2013;81:926–31. One of the first studies demonstrating the effect of CM beyond substance use rates, and effecting psychiatric symptoms.

    PubMed  Google Scholar 

  12. Kirby KC, Benishek LA, Dugosh KL, et al. Substance abuse treatment providers' beliefs and objections regarding contingency management: implications for dissemination. Drug Alcohol Depend. 2006;85:19–27.

    PubMed  Google Scholar 

  13. Benishek LA, Kirby KC, Dugosh KL, et al. Beliefs about the empirical support of drug abuse treatment interventions: a survey of outpatient treatment providers. Drug Alcohol Depend. 2010;107:202–8.

    PubMed  Google Scholar 

  14. Rash CJ, Petry NM, Kirby KC, et al. Identifying provider beliefs related to contingency management adoption using the contingency management beliefs questionnaire. Drug Alcohol Depend. 2012;121:205–12.

    PubMed  Google Scholar 

  15. Petry NM, Alessi SM, Marx J, et al. Vouchers versus prizes: contingency management treatment of substance abusers in community settings. J Consult Clin Psychol. 2005;73:1005–14.

    PubMed  Google Scholar 

  16. Petry NM, Peirce JM, Stitzer ML, et al. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse clinical trials network study. Arch Gen Psychiatry. 2006;62:1148–56.

    Google Scholar 

  17. Petry NM, Tedford J, Austin M, et al. Prize reinforcement contingency management for treating cocaine users: How low can we go, and with whom? Addiction. 2004;99:349–60.

    PubMed  Google Scholar 

  18. Packer RR, Howell DN, McPherson S, et al. Investigating reinforcer magnitude and reinforcer delay: a contingency management analog study. Exp Clin Psychopharmacol. 2012;20:287–92.

    PubMed  Google Scholar 

  19. Petry NM, Barry D, Alessi SM, et al. A randomized trial adapting contingency management targets based on initial abstinence status of cocaine-dependent patients. J Consult Clin Psychol. 2012;80:276–85. This trial used a novel adaptive design whereby participants were randomized based on initial urine results.

    PubMed  Google Scholar 

  20. Petry NM, Weinstock J, Alessi SM. A randomized trial of contingency management delivered in the context of group counseling. J Consult Clin Psychol. 2011;79:686–96.

    PubMed  Google Scholar 

  21. Roll JM, Chudzynski J, Cameron JM, et al. Duration effects in contingency management treatment of methamphetamine disorders. Addict Behav. 2013;38:2455–62.

    PubMed  Google Scholar 

  22. Carroll KM, Nich C, LaPaglia DM, et al. Combining cognitive behavioral therapy and contingency management to enhance their effects in treating cannabis dependence: less can be more, more or less. Addiction. 2012;107:1650–9.

    PubMed  Google Scholar 

  23. Rawson RA, McCann MJ, Flammino F, et al. A comparison of contingency management and cognitive-behavioral approaches for stimulant-dependent individuals. Addiction. 2006;101:267–74.

    PubMed  Google Scholar 

  24. Carroll KM, Rounsaville BJ. A perfect platform: combining contingency management with medications for drug abuse. Am J Drug Alcohol Abuse. 2007;33:343–65.

    PubMed  Google Scholar 

  25. Petry NM, Rash CJ, Byrne S, et al. Financial reinforcers for improving medication adherence: findings from a meta-analysis. Am J Med. 2012;125:888–96.

    PubMed  Google Scholar 

  26. Hartzler B, Lash SJ, Roll JM. Contingency management in substance abuse treatment: a structured review of the evidence for its transportability. Drug Alcohol Depend. 2012;122:1–10.

    PubMed  Google Scholar 

  27. Litt MD, Kadden RM, Kabela-Cormier E, et al. Coping skills training and contingency management treatments for marijuana dependence: exploring mechanisms of behavior change. Addiction. 2008;103:638–48.

    PubMed  Google Scholar 

  28. Stanger C, Budney AJ, Bickel WK. A developmental perspective on neuroeconomic mechanisms of contingency management. Psychol Addict Behav. 2013;27:403–15.

    PubMed  Google Scholar 

  29. Bickel WK, Miller ML, Yi R, et al. Behavioral and neuroeconomics of drug addiction: competing neural systems and temporal discounting processes. Drug Alcohol Depend. 2007;90 Suppl 1:S85–91.

    PubMed  Google Scholar 

  30. Bickel WK, Koffarnus MN, Moody L, et al. The behavioral- and neuro-economic process of temporal discounting: A candidate behavioral marker of addiction. Neuropharmacology. 2013 Jun 24 [Epub ahead of print]. Reviews the evidence regarding delay discounting and it's role as a potential mechanism of addiction treatments.

  31. Magill M, Ray LA. Cognitive-behavioral treatment with adult alcohol and illicit drug users: a meta-analysis of randomized controlled trials. J Stud Alcohol Drugs. 2009;70:516–27.

    PubMed  Google Scholar 

  32. McKee SA, Carroll KM, Sinha R, et al. Enhancing brief cognitive-behavioral therapy with motivational enhancement techniques in cocaine users. Drug Alcohol Depend. 2007;91:97–101.

    PubMed  Google Scholar 

  33. Babor TF. Brief treatments for cannabis dependence: findings from a randomized multisite trial. J Consult Clin Psychol. 2004;72:45–566.

    Google Scholar 

  34. Aharonovich E, Hasin DS, Brooks AC, et al. Cognitive deficits predict low treatment retention in cocaine dependent patients. Drug Alcohol Depend. 2006;81:313–22.

    PubMed  Google Scholar 

  35. Kiluk BD, Nich C, Carroll KM. Relationship of cognitive function and the acquisition of coping skills in computer assisted treatment for substance use disorders. Drug Alcohol Depend. 2011;114:169–76.

    PubMed  Google Scholar 

  36. Aharonovich E, Brooks AC, Nunes EV, et al. Cognitive deficits in marijuana users: effects on motivational enhancement therapy plus cognitive behavioral therapy treatment outcome. Drug Alcohol Depend. 2008;95:279–83.

    PubMed  Google Scholar 

  37. Aharonovich E, Nunes EV, Hasin D. Cognitive impairment, retention and abstinence among cocaine abusers in cognitive-behavioral treatment. Drug Alcohol Depend. 2003;71:207–11.

    PubMed  Google Scholar 

  38. Passetti F, Clark L, Mehta MA, et al. Neuropsychological predictors of clinical outcome in opiate addiction. Drug Alcohol Depend. 2008;94:82–91.

    PubMed  CAS  Google Scholar 

  39. Stavro K, Pelletier J, Potvin S. Widespread and sustained cognitive deficits in alcoholism: a meta-analysis. Addict Biol. 2013;18:203–13.

    PubMed  Google Scholar 

  40. Bolla KI, Brown K, Eldreth D, et al. Dose-related neurocognitive effects of marijuana use. Neurology. 2002;59:1337–43.

    PubMed  CAS  Google Scholar 

  41. Scott JC, Woods SP, Matt GE, et al. Neurocognitive effects of methamphetamine: a critical review and meta-analysis. Neuropsychol Rev. 2007;17:275–97.

    PubMed  Google Scholar 

  42. Baldacchino A, Balfour DJ, Passetti F, et al. Neuropsychological consequences of chronic opioid use: a quantitative review and meta-analysis. Neurosci Biobehav Rev. 2012;36:2056–68.

    PubMed  CAS  Google Scholar 

  43. Sofuoglu M, DeVito EE, Waters AJ, et al. Cognitive enhancement as a treatment for drug addictions. Neuropharmacology. 2013;64:452–63.

    PubMed  CAS  Google Scholar 

  44. Medalia A, Choi J. Cognitive remediation in schizophrenia. Neuropsychol Rev. 2009;19:353–64.

    PubMed  Google Scholar 

  45. Houben K, Wiers RW, Jansen A. Getting a grip on drinking behavior: training working memory to reduce alcohol abuse. Psychol Sci. 2011;22:968–75.

    PubMed  Google Scholar 

  46. Bickel W, Yi R, Landes R, et al. Remember the future: working memory training decreases delay discounting among stimulant addicts. Biol Psychiatry. 2011;69:260–5. One of the first successful demonstrations of the effect of computerized cognitive remediation on potential markers of addiction.

    PubMed  Google Scholar 

  47. Rupp CI, Kemmler G, Kurz M, et al. Cognitive remediation therapy during treatment for alcohol dependence. J Stud Alcohol Drugs. 2012;73:625–34.

    PubMed  Google Scholar 

  48. Sofuoglu M, Carroll KM. Effects of galantamine on cocaine use in chronic cocaine users. Am J Addict. 2011;20:302–3.

    PubMed  Google Scholar 

  49. Sofuoglu M, Waters AJ, Poling J, et al. Galantamine improves sustained attention in chronic cocaine users. Exp Clin Psychopharmacol. 2011;19:11–9.

    PubMed  Google Scholar 

  50. Carroll KM, Rounsaville BJ. A vision of the next generation of behavioral therapies research in the addictions. Addiction. 2007;102:850–62.

    PubMed  Google Scholar 

  51. Carroll KM, Ball SA, Martino S, et al. Computer-assisted cognitive-behavioral therapy for addiction. A randomized clinical trial of 'CBT4CBT'. Am J Psychiatry. 2008;165:881–8.

    PubMed  Google Scholar 

  52. Carroll KM. A cognitive-behavioral approach: treating cocaine addiction. Therapy manuals for drug addiction. NIDA: Rockville; 1998.

    Google Scholar 

  53. Carroll KM, Ball SA, Martino S, et al. Enduring effects of a computer-assisted training program for cognitive behavioral therapy: a 6-month follow-up of CBT4CBT. Drug Alcohol Depend. 2009;100:178–81.

    PubMed  Google Scholar 

  54. Carroll KM, Kiluk BD, Nich C, et al. Computer-assisted delivery of cognitive behavioral therapy: Efficacy and durability of CBT4CBT among cocaine dependent individuals maintained on methadone.

  55. Morgenstern J, Longabaugh R. Cognitive-behavioral treatment for alcohol dependence: a review of the evidence for its hypothesized mechanisms of action. Addiction. 2000;95:1475–90.

    PubMed  CAS  Google Scholar 

  56. Kiluk BD, Nich C, Babuscio T, et al. Quantity vs. Quality: acquisition of coping skills following computerized cognitive behavioral therapy for substance use disorders. Addiction. 2010;105:2120–7. This is one of the first studies to demonstrate statistical mediation, supporting coping skills as a mediator of the effect of CBT on substance use rates.

    PubMed  Google Scholar 

  57. Miller WR, Rollnick S. Motivational interviewing: preparing people for change. 2nd ed. New York: Guilford Press; 2002.

    Google Scholar 

  58. Miller WR, Zweben A, DiClemente CC, et al. Motivational enhancement therapy manual: a clinical research guide for therapists treating individuals with alcohol abuse and dependence. Project MATCH monograph series number 2. NIAAA: Rockville; 1992.

    Google Scholar 

  59. Burke BL, Arkowitz H, Menchola M. The efficacy of motivational interviewing: a meta-analysis of controlled clinical trials. J Consult Clin Psychol. 2003;71:843–61.

    PubMed  Google Scholar 

  60. Hettema J, Steele J, Miller WR. Motivational interviewing. Annu Rev Clin Psychol. 2005;1:91–111.

    PubMed  Google Scholar 

  61. Smedslund G, Berg RC, Hammerstrom KT, et al. Motivational interviewing for substance abuse. Cochrane Database Syst Rev. 2011;5:CD008063.

    PubMed  Google Scholar 

  62. Seigers DK, Carey KB. Screening and brief interventions for alcohol use in college health centers: a review. J Am Coll Health. 2011;59:151–8.

    PubMed  Google Scholar 

  63. Barnett E, Sussman S, Smith C, et al. Motivational interviewing for adolescent substance use: a review of the literature. Addict Behav. 2012;37:1325–34.

    PubMed  Google Scholar 

  64. Apodaca TR, Longabaugh R. Mechanisms of change in motivational interviewing: a review and preliminary evaluation of the evidence. Addiction. 2009;104:705–15.

    PubMed  Google Scholar 

  65. Moyers TB, Martin T, Christopher PJ, et al. Client language as a mediator of motivational interviewing efficacy: where is the evidence? Alcohol Clin Exp Res. 2007;31(10 Suppl):40s–7s.

    PubMed  Google Scholar 

  66. Moyers TB, Martin T, Houck JM, et al. From in-session behaviors to drinking outcomes: a causal chain for motivational interviewing. J Consult Clin Psychol. 2009;77:1113–24.

    PubMed  Google Scholar 

  67. Morgenstern J, Kuerbis A, Amrhein P, et al. Motivational interviewing: a pilot test of active ingredients and mechanisms of change. Psychol Addict Behav. 2012;26:859–69. Highlights the value of study designs that experimentally manipulate the hypothesized active ingredients for understanding mechanisms of action.

    PubMed  Google Scholar 

  68. Bowen S, Chawla N, Marlatt GA. Mindfulness-based relapse prevention for the treatment of substance use disorders: a clinician's guide. New York: Guilford Press; 2010.

    Google Scholar 

  69. Bowen S, Chawla N, Collins SE, et al. Mindfulness-based relapse prevention for substance use disorders: a pilot efficacy trial. Subst Abus. 2009;30:295–305.

    PubMed  Google Scholar 

  70. Witkiewitz K, Lustyk MK, Bowen S. Retraining the addicted brain: a review of hypothesized neurobiological mechanisms of mindfulness-based relapse prevention. Psychol Addict Behav. 2013;27:351–65.

    PubMed  Google Scholar 

  71. Sinha R, Garcia M, Paliwal P, et al. Stress-induced cocaine craving and hypothalamic-pituitary-adrenal responses are predictive of cocaine relapse outcomes. Arch Gen Psychiatry. 2006;63:324–31.

    PubMed  Google Scholar 

  72. Witkiewitz K, Bowen S, Douglas H, et al. Mindfulness-based relapse prevention for substance craving. Addict Behav. 2013;38:1563–71.

    PubMed  Google Scholar 

  73. Zgierska A, Rabago D, Chawla N, et al. Mindfulness meditation for substance use disorders: a systematic review. Subst Abus. 2009;30(4):266–94.

    PubMed  Google Scholar 

  74. Dallery J, Glenn IM, Raiff BR. An internet-based abstinence reinforcement treatment for cigarette smoking. Drug Alcohol Depend. 2007;86:230–8.

    PubMed  Google Scholar 

  75. Alessi SM, Petry NM. A randomized study of cellphone technology to reinforce alcohol abstinence in the natural environment. Addiction. 2013;108:900–9.

    PubMed  Google Scholar 

  76. Bickel WK, Marsch LA, Buchhalter AR, et al. Computerized behavior therapy for opioid-dependent outpatients: a randomized controlled trial. Exp Clin Psychopharmacol. 2008;16:132–43.

    PubMed  CAS  Google Scholar 

  77. Ondersma SJ, Chase SK, Svikis DS, et al. Computer-based brief motivational intervention for perinatal drug use. J Subst Abuse Treat. 2005;28:305–12.

    PubMed  Google Scholar 

  78. Hester RK, Delaney HD, Campbell W. The college drinker's check-up: outcomes of two randomized clinical trials of a computer-delivered intervention. Psychol Addict Behav. 2012;26:1–12.

    PubMed  Google Scholar 

  79. Walters ST, Ondersma SJ, Ingersoll KS, et al. MAPIT: Development of a web-based intervention targeting substance abuse treatment in the criminal justice system. J Subst Abuse Treat. 2013 Aug 16 [Epub ahead of print].

  80. Budney AJ, Fearer S, Walker DD, et al. An initial trial of a computerized behavioral intervention for cannabis use disorder. Drug Alcohol Depend. 2011;115:74–9.

    PubMed  Google Scholar 

  81. Kay-Lambkin FJ, Baker AL, Lewin TJ, et al. Computer based psychological treatment for comorbid depression and problematic alcohol and/or cannabis use: a randomized controlled trial of clinical efficacy. Addiction. 2009;104:378–88.

    PubMed  Google Scholar 

  82. Bickel WK, Christensen DR, Marsch LA. A review of computer-based interventions used in the assessment, treatment, and research of drug addiction. Subst Use Misuse. 2011;46:4–9.

    PubMed  Google Scholar 

  83. Moore BA, Fazzino T, Garnet B, et al. Computer-based interventions for drug use disorders: a systematic review. J Subst Abuse Treat. 2011;40:215–23.

    PubMed  Google Scholar 

  84. Marsch LA, Dallery J. Advances in the psychosocial treatment of addiction: the role of technology in the delivery of evidence-based psychosocial treatment. Psychiatr Clin North Am. 2012;35:481–93.

    PubMed  Google Scholar 

  85. Johnson K, Isham A, Shah DV, et al. Potential roles for new communication technologies in treatment of addiction. Curr Psychiatry Rep. 2011;13:390–7. Describes the recent advances in technology and how they can be applied to treatments for substance use disorders.

    PubMed  Google Scholar 

  86. Boyer EW, Smelson D, Fletcher R, et al. Wireless technologies, ubiquitous computing and mobile health: application to drug abuse treatment and compliance with HIV therapies. J Med Toxicol. 2010;6:212–6.

    PubMed  Google Scholar 

  87. Marks IM, Cuijpers P, Cavanagh K, et al. Meta-analysis of computer-aided psychotherapy: problems and partial solutions. Cogn Behav Ther. 2009;38:83–90.

    PubMed  Google Scholar 

  88. Cuijpers P, Marks IM, van Straten A, et al. Computer-aided psychotherapy for anxiety disorders: a meta-analytic review. Cogn Behav Ther. 2009;38:66–82.

    PubMed  Google Scholar 

  89. Kaltenthaler E, Brazier J, De Nigris E, et al. Computerised cognitive behaviour therapy for depression and anxiety update: a systematic review and economic evaluation. Health Technol Assess. 2006;10:1–168. iii, xi–xiv.

    Google Scholar 

  90. Olmstead TA, Ostrow CD, Carroll KM. Cost-effectiveness of computer-assisted training in cognitive-behavioral therapy as an adjunct to standard care for addiction. Drug Alcohol Depend. 2010;110:200–7.

    PubMed  Google Scholar 

  91. Substance Abuse and Mental Health Service Administration (SAMHSA). Results from the 2011 national survey on drug use and health: summary of national findings, U.S. Department of health and human services, ed. Rockville: SAMHSA; 2012.

    Google Scholar 

  92. Kiluk BD, Sugarman D, Nich C, et al. A methodological analysis of randomized clinical trials of computer-assisted therapies for psychiatric disorders: towards improved standards for an emerging field. Am J Psychiatry. 2011;168:790–9. Describes the current state of the science of technology-based interventions, including defining a set of standards for trials evaluating their effectiveness.

    PubMed  Google Scholar 

  93. Chambless DL, Hollon SD. Defining empirically supported therapies. J Consult Clin Psychol. 1998;66:7–18.

    PubMed  CAS  Google Scholar 

  94. Morgenstern J, McKay JR. Rethinking the paradigms that inform behavioral treatment research for substance use disorders. Addiction. 2007;102:1377–89.

    PubMed  Google Scholar 

  95. Morgenstern J, Naqvi NH, Debellis R, et al. The contributions of cognitive neuroscience and neuroimaging to understanding mechanisms of behavior change in addiction. Psychol Addict Behav. 2013;27:336–50. Outlines how neurocognitive theories of addiction can inform behavioral treatments and their mechanisms of action.

    PubMed  Google Scholar 

  96. Bechara A. Decision making, impulse control and loss of willpower to resist drugs: a neurocognitive perspective. Nat Neurosci. 2005;8:1458–63.

    PubMed  CAS  Google Scholar 

  97. Noel X, Brevers D, Bechara A. A neurocognitive approach to understanding the neurobiology of addiction. Curr Opin Neurobiol. 2013;23:632–8.

    PubMed  CAS  Google Scholar 

  98. Stacy AW, Wiers RW. Implicit cognition and addiction: a tool for explaining paradoxical behavior. Annu Rev Clin Psychol. 2010;6:551–75.

    PubMed  Google Scholar 

  99. Field M, Schoenmakers T, Wiers RW. Cognitive processes in alcohol binges: a review and research agenda. Curr Drug Abuse Rev. 2008;1:263–79.

    PubMed  Google Scholar 

  100. Field M, Cox WM. Attentional bias in addictive behaviors: a review of its development, causes, and consequences. Drug Alcohol Depend. 2008;97:1–20.

    PubMed  Google Scholar 

  101. Wiers RW, Bartholow BD, van den Wildenberg E, et al. Automatic and controlled processes and the development of addictive behaviors in adolescents: a review and a model. Pharmacol Biochem Behav. 2007;86:263–83.

    PubMed  CAS  Google Scholar 

  102. Wiers RW, Rinck M, Dictus M, et al. Relatively strong automatic appetitive action-tendencies in male carriers of the OPRM1 G-allele. Genes Brain Behav. 2009;8:101–6.

    PubMed  CAS  Google Scholar 

  103. Wiers RW, Rinck M, Kordts R, et al. Retraining automatic action-tendencies to approach alcohol in hazardous drinkers. Addiction. 2010;105:279–87. Describes the use of a novel intervention for retraining automatic action tendencies and it's effect on reducing drinking behavior after relatively few sessions. This work sets the stage for future investigations of neurocognitive interventions designed to address underlying brain processes.

    PubMed  Google Scholar 

  104. Wiers RW, Eberl C, Rinck M, et al. Retraining automatic action tendencies changes alcoholic patients' approach bias for alcohol and improves treatment outcome. Psychol Sci. 2011;22:490–7.

    PubMed  Google Scholar 

  105. Eberl C, Wiers RW, Pawelczack S, et al. Approach bias modification in alcohol dependence: do clinical effects replicate and for whom does it work best? Dev Cogn Neurosci. 2013;4:38–51.

    PubMed  Google Scholar 

  106. Klingberg T. Training and plasticity of working memory. Trends Cogn Sci. 2010;14:317–24.

    PubMed  Google Scholar 

  107. Vinogradov S, Fisher M, de Villers-Sidani E. Cognitive training for impaired neural systems in neuropsychiatric illness. Neuropsychopharmacology. 2012;37:43–76. Presents a thorough review of cognitive training approaches and neuroscience-informed recommendations for future interventions.

    PubMed  Google Scholar 

Download references

Acknowledgments

Dr. Kiluk and Dr. Carroll’s work is supported, in part, through National Institute on Drug Abuse grants P50-DA09241, and R01-DA015969.

Compliance with Ethics Guidelines

ᅟ

Conflict of Interest

Brian D. Kiluk declares that he has no conflict of interest. Kathleen M. Carroll is a member of CBT4CBT LLC, which makes CBT4CBT available to qualified clinical providers and organizations on a commercial basis. Dr. Carroll works with Yale University to manage any potential conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. Department of Psychiatry, Yale School of Medicine, New Haven, CT, 06511, USA

    Brian D. Kiluk

  2. Department of Psychiatry, Yale School of Medicine, West Haven, CT, USA

    Kathleen M. Carroll

Authors
  1. Brian D. Kiluk
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kathleen M. Carroll
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Brian D. Kiluk.

Additional information

This article is part of the Topical Collection on Substance Use and Related Disorders

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kiluk, B.D., Carroll, K.M. New Developments in Behavioral Treatments for Substance Use Disorders. Curr Psychiatry Rep 15, 420 (2013). https://doi.org/10.1007/s11920-013-0420-1

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11920-013-0420-1

Keywords

Search

Navigation